IUI Stock Overview

Develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. More details

IUI fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	2/6
Past Performance	5/6
Financial Health	6/6
Dividends	0/6

Rewards

Earnings are forecast to grow 12.85% per year

Earnings grew by 29.2% over the past year

Risk Analysis

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Intuitive Surgical, Inc. Competitors

Siemens Healthineers

XTRA:SHL

€63.0b

Carl Zeiss Meditec

XTRA:AFX

€4.8b

Eckert & Ziegler

XTRA:EUZ

€1.2b

Drägerwerk KGaA

XTRA:DRW3

€947.2m

Price History & Performance

Summary of share price highs, lows and changes for Intuitive Surgical
Historical stock prices
Current Share Price	US$21.40
52 Week High	US$21.42
52 Week Low	US$20.95
Beta	1.39
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-0.093%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	IUI	DE Medical Equipment	DE Market
7D	-0.09%	-1.5%	3.0%
1Y	n/a	-2.6%	19.3%

Return vs Industry: Insufficient data to determine how IUI performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how IUI performed against the German Market.

Price Volatility

Is IUI's price volatile compared to industry and market?
IUI volatility
IUI Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.8%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	11.4%
10% least volatile stocks in DE Market	2.5%

Stable Share Price: IUI's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine IUI's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1995	15,638	Gary Guthart	www.intuitive.com

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights.

Intuitive Surgical, Inc. Fundamentals Summary

How do Intuitive Surgical's earnings and revenue compare to its market cap?
IUI fundamental statistics
Market cap	€205.91b
Earnings (TTM)	€2.23b
Revenue (TTM)	€8.02b

92.3x

P/E Ratio

25.7x

P/S Ratio

Is IUI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IUI income statement (TTM)
Revenue	US$8.35b
Cost of Revenue	US$2.72b
Gross Profit	US$5.63b
Other Expenses	US$3.31b
Earnings	US$2.32b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	6.51
Gross Margin	67.46%
Net Profit Margin	27.81%
Debt/Equity Ratio	0%

How did IUI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/19 22:32
End of Day Share Price	2025/02/19 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Intuitive Surgical, Inc. is covered by 59 analysts. 30 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
null null	Argus Research Company
David Toung	Argus Research Company
Richard Purkiss	Atlantic Equities LLP